BridgeMD
Tests treatment safety and results for Spinal Cord Injuries (SCI)
Official title Study on Preliminary Safety and Efficacy of Epidural Electrical Stimulation to Manage Lower Urinary Tract Dysfunction After Spinal Cord Injury
ClinicalTrials.gov ID: NCT06845904
What this study is testing
- What it's testing
- This clinical trial aims to assess the preliminary safety and efficacy of Epidural Electrical Stimulation (EES) therapy in managing lower urinary tract dysfunction in individuals with sub-acute or chronic spinal cord injury (SCI). The study evaluates the therapy's potential to improve urinary function and prevent neurogenic detrusor overactivity, ultimately seeking to enhance quality of life for individuals with SCI.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age 18 or older;
- Must provide and sign the Informed Consent Form prior to any study-related procedures;
- Spinal cord injury lesion level above T11 (inclusive);
- SCI graded as AIS- B, C or D;
- SCI ≥ 6 months;
You likely can't join if
- Botulinum toxin vesical injections in the previous 6 months;
- Presence of non-pharmacological treatments for lower urinary tract dysfunction (e.g. sacral nerve stimulation);
- Does have or needs a suprapubic catheter or bladder indwelling catheter;
- Presence of upper urinary tract dilatation or bladder or renal stones;
- Presence of urethral stricture or significant benign prostate hyperplasia;
- Presence of significant pressure ulcers;
See the full eligibility criteria
- Age 18 or older;
- Must provide and sign the Informed Consent Form prior to any study-related procedures;
- Spinal cord injury lesion level above T11 (inclusive);
- SCI graded as AIS- B, C or D;
- SCI ≥ 6 months;
- Confirmed lower urinary tract dysfunction during urodynamic assessment (NDO, DSD);
- Intolerant, refractory or inefficient to conservative treatment options such as medications and behavioural management;
- Using intermittent self-catheterization;
- Stable medical, physical and psychological condition as considered by the investigators;
- Able to understand and interact with the study team in French or English;
- Agrees to comply in good faith with all conditions of the study and to attend all scheduled appointments;
- Botulinum toxin vesical injections in the previous 6 months;
- Presence of non-pharmacological treatments for lower urinary tract dysfunction (e.g. sacral nerve stimulation);
- Does have or needs a suprapubic catheter or bladder indwelling catheter;
- Presence of upper urinary tract dilatation or bladder or renal stones;
- Presence of urethral stricture or significant benign prostate hyperplasia;
- Presence of significant pressure ulcers;
- Previous lower urinary tract surgery;
- Presence of Autonomic Dysreflexia during urodynamic test;
- Recurrent and symptomatic urinary tract infection (more than 3 per year);
- Presence of intrathecal baclofen pump;
- Diseases and conditions that would increase the morbidity and mortality of spinal surgery;
- Other clinically significant concomitant disease states (e.g., syringomyelia, bladder cancer, renal failure, hepatic dysfunction, cardiovascular disease, etc.);
- The inability to withhold antiplatelet/anticoagulation agents perioperatively;
- Presence of pacemakers for cardiac conditions;
- Other conditions that would make the subject unable to participate in testing in the judgement of the investigators;
- Women who are pregnant (pregnancy test obligatory for woman of childbearing potential) or breast feeding;
- Lack of acceptable or highly effective method of contraception for women of childbearing capacity;
- Intention to become pregnant during the course of the study;
- Inability to follow the procedures of the study, e.g. due to language problems, mental illness, psychological disorders, or dementia of the participant;
- Participation in another study with investigational drug or device within the 30 days preceding and during the present study;
- Have any indication that would require Magnetic Resonance Imaging (MRI)
- Is the investigator himself, his/her family members, employees or other dependent persons.
The study team makes the final eligibility decision.
Where it's taking place
- Lausanne, Canton of Vaud, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lausanne, Canton of Vaud, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.